Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00815568
What this trial is testing

Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI)

Who this might be right for
AMLMDSALL+2 more
Samsung Medical Center 114
Testing effectiveness (Phase 2)Looking for participantsNCT07532824
What this trial is testing

Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)/AMLProton Therapy+2 more
Institute of Hematology and Blood Transfusion, Czech Republic 16
Testing effectiveness (Phase 2)Looking for participantsNCT07301866
What this trial is testing

A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe.

Who this might be right for
Acute Leukemia, High RiskMyelodysplastic Syndromes, High RiskHematologic Malignancy Requiring an Allogeneic Hematopoietic Stem Cell Transplant Lacking a Donor
Ciusss de L'Est de l'Île de Montréal 7
Early research (Phase 1)Ended earlyNCT01663766
What this trial is testing

Phase I Study of Milatuzumab for Graft Versus Host Disease

Who this might be right for
GVHD (Acute or Chronic)Acute Myeloid or Lymphoblastic Leukemia (AML or ALL)Myelodysplastic Syndrome+4 more
Gilead Sciences 12
Testing effectiveness (Phase 2)Study completedNCT03812705
What this trial is testing

Fecal Microbiota Transplantation for Steroid Resistant/Dependent Acute GI GVHD

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 6
Testing effectiveness (Phase 2)Study completedNCT00185796
What this trial is testing

TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD

Who this might be right for
Myeloproliferative DisordersBlood CancerMyelodysplastic Syndromes
Stanford University 77
Testing effectiveness (Phase 2)Ended earlyNCT01139164
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3)

Who this might be right for
Hematological Malignancies
Medical University of South Carolina 78
Testing effectiveness (Phase 2)Study completedNCT00673114
What this trial is testing

Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies

Who this might be right for
Hematologic MalignancyMyelodysplastic Syndrome (MDS)Aplastic Anemia
Joanne Kurtzberg, MD 3
Early research (Phase 1)Looking for participantsNCT06551584
What this trial is testing

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMixed Phenotype Acute Leukemia+1 more
Stanford University 24
Testing effectiveness (Phase 2)UnknownNCT03091933
What this trial is testing

Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)

Who this might be right for
Hematologic CancerRelapse LeukemiaRelapsed Adult ALL+6 more
Ciusss de L'Est de l'Île de Montréal 20
Testing effectiveness (Phase 2)WithdrawnNCT01326273
What this trial is testing

Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation

Who this might be right for
CMV ReactivationAllogeneic Stem Cell TransplantationAutologous CMV Specific CD8+ T Cells
Imperial College London
Testing effectiveness (Phase 2)Study completedNCT00144703
What this trial is testing

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation

Who this might be right for
Hematologic MalignanciesMyelogenous LeukemiaAcute Lymphoblastic Leukemia+3 more
Dana-Farber Cancer Institute 55
Testing effectiveness (Phase 2)Study completedNCT00852163
What this trial is testing

Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen

Who this might be right for
LeukemiaMyelodysplastic Syndrome
Baylor Research Institute 20
Large-scale testing (Phase 3)Study completedNCT00469729
What this trial is testing

Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy

Who this might be right for
Hematologic MalignanciesAcute Myeloid LeukemiaLymphoid Leukemia+4 more
Gamida Cell -Teva Joint Venture Ltd. 101
Large-scale testing (Phase 3)Active Not RecruitingNCT05316701
What this trial is testing

Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMixed Phenotype Acute Leukemia+4 more
Orca Biosystems, Inc. 187
Not applicableUnknownNCT04323605
What this trial is testing

Assistance Program for Outpatients Following an Allogeneic Hematopoietic Stem-cell Transplant

Who this might be right for
Hematologic Neoplasms
University Hospital, Toulouse 50
Not applicableStudy completedNCT01081405
What this trial is testing

Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
HEMATOLOGIC MALIGNANCIES
Fondazione EMN Italy Onlus 20
Not applicableStudy completedNCT04966156
What this trial is testing

Cancer Rehab Program for Allogenic Bone and Marrow Transplant Patients - CaRE-4-alloBMT

Who this might be right for
Allogeneic DiseaseHematologic CancerCancer Rehabilitation
University Health Network, Toronto 80
Testing effectiveness (Phase 2)Study completedNCT00475020
What this trial is testing

Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome

Who this might be right for
Myelofibrosis
M.D. Anderson Cancer Center 63
Not applicableStudy completedNCT00582894
What this trial is testing

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases

Who this might be right for
Hematological NeoplasmsHematopoietic Stem Cell Transplantation
University of Oklahoma 17
Next Page